IBIO, INC. Contract Liability (Deferred Revenue)
IBIO, INC. (IBIO) had Contract Liability (Deferred Revenue) of $1.15 million as of 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-28
- 2026-06-30: Contract with Customer, Liability, Current $1.15M.
- 2026-03-31: Contract with Customer, Liability, Current $1.15M.
- 2025-12-31: Contract with Customer, Liability, Current $1.15M.
- 2025-09-30: Contract with Customer, Liability, Current $1.15M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $1.15M 10-K · filed 2026-08-28 |
| 2026-03-31 | $1.15M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $1.15M 10-Q · filed 2026-02-10 |
| 2025-09-30 | $1.15M 10-Q/A · filed 2025-11-17 |
| 2025-06-30 | $1.20M 10-K · filed 2026-08-28 |
| 2025-03-31 | $600.00K 10-Q · filed 2025-05-02 |
| 2024-12-31 | $600.00K 10-Q · filed 2025-02-10 |
| 2024-09-30 | $400.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $200.00K 10-K · filed 2026-08-28 |
| 2024-03-31 | $175.00K 10-Q · filed 2024-05-13 |
| 2023-06-30 | $0.00 10-K · filed 2025-09-05 |
| 2022-06-30 | $100.00K 10-K/A · filed 2024-09-24 |
| 2021-03-31 | $886.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.23M 10-Q · filed 2021-02-16 |
| 2020-09-30 | $1.37M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $1.81M 10-Q · filed 2021-05-17 |
| 2020-03-31 | $3.01M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $3.03M 10-Q · filed 2020-02-14 |
| 2019-09-30 | $2.89M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.28M 10-K · filed 2020-10-13 |
| 2019-03-31 | $2.04M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $2.53M 10-Q · filed 2019-02-13 |
| 2018-06-30 | $0.00 10-K · filed 2019-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |